drugset / Trial / NCT01128322
CKD-828 Primary Hypertension Trial(Dose-selection)
RandomizedFactorialTriple-blindTreatment
Summary
The aim of this trial is to determine the best dose combination of S-Amlodipine and Telmisartan as compared to monotherapy by assessing the blood pressure lowering effects of a once daily regimen of various combinations of S-Amlodipine and Telmisartan, compared to their monotherapy components and placebo, in patients with stage I or II essential hypertension(a mean seated cuff diastolic blood pressure \>=95 and \<=115 mmHg).
Timeline
- Start
- 2010-07
- Primary completion
- 2011-03
- Completion
- 2011-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | S-amlodipine | Unknown | 2.5 mg | — |
| Comparator | S-amlodipine | Unknown | 5 mg | — |
| Comparator | Telmisartan | Other / unclassified | 40 mg | — |
| Comparator | Telmisartan | Other / unclassified | 80 mg | — |